愛德華生命科學EW
紐約證券 · USD
84.24
+0.32
(+0.38%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
愛德華生命科學EW
84.24
+0.32
(+0.38%)
財務數據
損益表
- 15.30
- 19.38
- 22.61
- 15.98
- 14.03
- 13.21
- 13.86
- 14.13
- 15.32
- 15.53
- 4.84
- 26.62
- 16.71
- -29.32
- -12.22
- -5.85
- 4.91
- 1.94
- 8.46
- 1.36
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 1,553,100 | 1,532,200 | 1,412,700 | 1,385,800 | 1,320,900 | 1,402,900 | 1,598,200 | 2,261,200 | 1,937,500 | 1,530,200 |
營業成本 | 345,200 | 344,400 | 301,600 | 292,200 | 243,700 | 294,700 | 385,600 | 652,400 | 527,000 | 343,000 |
營業毛利 | 1,207,900 | 1,187,800 | 1,111,100 | 1,093,600 | 1,077,200 | 1,108,200 | 1,212,600 | 1,608,800 | 1,410,500 | 1,187,200 |
營業費用 | 900,800 | 776,600 | - | 781,000 | - | - | - | 1,036,800 | 877,700 | 860,000 |
研發費用 | 280,700 | 276,200 | 254,600 | 271,100 | 251,500 | 273,700 | 285,200 | 351,000 | 323,300 | 270,300 |
推銷及管理費用 | 481,200 | 484,900 | 450,800 | 469,200 | 436,100 | 455,200 | 531,000 | 675,900 | 552,200 | 441,800 |
非經常性項目費用 | 138,900 | 15,500 | 10,900 | 40,700 | 43,700 | 8,100 | 8,900 | 9,900 | 2,200 | 147,900 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 307,100 | 411,200 | 394,800 | 312,600 | 345,900 | 371,200 | 387,500 | 572,000 | 532,800 | 327,200 |
其他收入及費用 | 41,300 | -11,000 | 39,100 | 97,300 | 52,200 | 17,500 | 21,900 | 38,500 | 21,000 | 11,300 |
利息費用 | - | - | - | 19,800 | - | - | - | 17,600 | - | - |
稅前純益 | 348,400 | 400,200 | 433,900 | 390,100 | 398,100 | 388,700 | 409,400 | 592,900 | 553,800 | 338,500 |
所得稅 | 56,100 | 64,300 | 70,300 | 45,100 | 40,200 | 20,500 | 58,400 | 80,400 | 80,500 | 33,000 |
稅後純益 | 291,100 | 333,200 | 358,000 | 385,600 | 3,070,800 | 366,300 | 351,900 | 369,900 | 384,900 | 307,100 |
基本每股稅後盈餘(元) | 0.50 | 0.57 | 0.61 | 0.65 | 5.14 | 0.61 | 0.58 | 0.61 | 0.63 | 0.51 |
稀釋每股稅後盈餘(元) | 0.49 | 0.57 | 0.61 | 0.68 | 5.10 | 0.61 | 0.58 | 0.61 | 0.63 | 0.50 |
基本平均股數(千股) | 584700.00 | 587000.00 | 586900.00 | 589800.00 | 597200.00 | 602100.00 | 601600.00 | 605200.00 | 607000.00 | 606900.00 |
稀釋平均股數(千股) | 585700.00 | 587900.00 | 587800.00 | 590500.00 | 598100.00 | 604300.00 | 604100.00 | 606900.00 | 609500.00 | 610300.00 |
還原基本每股稅後盈餘(元) | 0.50 | 0.57 | 0.61 | 0.65 | 5.14 | 0.61 | 0.58 | 0.61 | 0.63 | 0.51 |
還原稀釋每股稅後盈餘(元) | 0.49 | 0.57 | 0.61 | 0.68 | 5.10 | 0.61 | 0.58 | 0.61 | 0.63 | 0.50 |
還原基本平均股數(千股) | 584,700 | 587,000 | 586,900 | 589,800 | 597,200 | 602,100 | 601,600 | 605,200 | 607,000 | 606,900 |
還原稀釋平均股數(千股) | 585,700 | 587,900 | 587,800 | 590,500 | 598,100 | 604,300 | 604,100 | 606,900 | 609,500 | 610,300 |
EBITDA(千元) | 386,400 | 435,600 | 464,900 | 493,100 | 3,145,500 | 426,400 | 448,800 | 504,600 | 502,300 | 376,200 |